Minerva Neurosciences, Inc. — Director's Dealing 2017

Dec 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-12-13

Reporting Person: Davidson Michael (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-13	Employee Stock Option (Right to Buy)	$6.10	A	125000	Acquired	2027-12-13	Common Stock (125000)	Direct

Footnotes

F1: This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.